Background In patients with breast cancer who are candidates for neoadjuvant therapy
(NAT), the timing of when to perform sentinel lymph node biopsy (SLNB) remains under …

Results Lymphoscintigraphy showed no axillary lymphatic drainage in 7 patients (41%), and
no sentinel lymph node could be identified during surgery in these patients. Axillary lymph …

Background Recent trials have suggested the feasibility of performing a sentinel lymph node
biopsy (SNB) following neoadjuvant chemotherapy (NAC). The selection of suitable patients …

Sentinel lymph node dissection (SLND) is a standard axillary staging technique in breast
cancer and intraoperative sentinel lymph node (SLN) assessment is important for decision …

Few areas of modern medicine have captured the imagination more than the rapid and
groundbreaking progress that has been observed in the treatment of patients with early …

We prospectively studied the feasibility of sentinel lymph node biopsy (SLNB) after
neoadjuvant chemotherapy by comparing the identification rate and the false-negative rate …

Background Histological status of axillary lymph nodes is an important prognostic factor in
patients receiving surgery for breast cancer (BC). Sentinel lymph node (SLN) biopsy (B) has …

Use of sentinel lymph node biopsy for axillary staging of patients with breast cancer treated
with neoadjuvant chemotherapy has been widely debated. Questions arise regarding the …

Axillary lymph node status is the most important prognostic factor in the treatment of breast
cancer. In recent years, sentinel lymph node biopsy (SLNB) has replaced conventional …

Importance Sentinel lymph node (SLN) surgery provides reliable nodal staging information
with less morbidity than axillary lymph node dissection (ALND) for patients with clinically …